Title : Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.

Pub. Date : 2014 Jul 7

PMID : 24830852






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Daunorubicin (DNR) demonstrated a 2.2- and 3.5-fold higher cytotoxicity with the HL formulation and a 1.2- and 2.0-fold higher cytotoxicity with the LL formulation compared to the unmodified liposomal formulation in THP-1 and NB4 cells, respectively. Daunorubicin GLI family zinc finger 2 Homo sapiens
2 Daunorubicin (DNR) demonstrated a 2.2- and 3.5-fold higher cytotoxicity with the HL formulation and a 1.2- and 2.0-fold higher cytotoxicity with the LL formulation compared to the unmodified liposomal formulation in THP-1 and NB4 cells, respectively. Daunorubicin GLI family zinc finger 2 Homo sapiens